𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Activity of SU11248, a Multitargeted Inhibitor of Vascular Endothelial Growth Factor Receptor and Platelet-Derived Growth Factor Receptor, in Patients With Metastatic Renal Cell Carcinoma

✍ Scribed by Kibel, A.S.; Ornstein, D.K.; Finley, D.S.

Book ID
121983676
Publisher
Elsevier Science
Year
2007
Weight
61 KB
Volume
2007
Category
Article
ISSN
0084-4071

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Clinical significance of vascular endoth
Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma
✍ Mitsuyuki Arinaga; Tsuyoshi Noguchi; Shinsuke Takeno; Masao Chujo; Takashi Miura πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 491 KB πŸ‘ 1 views

## Abstract ## BACKGROUND Vascular endothelial growth factor C (VEGF‐C) plays an important role in lymphangiogenesis and activates VEGF receptor 3 (VEGFR‐3). By contrast, lymphatic spread is an important prognostic factor in patients with nonsmall cell lung carcinoma (NSCLC). The objective of the

The significance of thymidine phosphoryl
The significance of thymidine phosphorylase/platelet-derived endothelial cell growth factor activity in renal cell carcinoma
✍ Yoichi Mizutani; Hiromi Wada; Osamu Yoshida; Masakazu Fukushima; Akihiro Kawauch πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 88 KB

## Abstract ## BACKGROUND Thymidine phosphorylase (TP) is identical to platelet‐derived endothelial cell growth factor (PDECGF) and has angiogenic activity. Little is known about the significance of TP/PDECGF activity in patients with renal cell carcinoma (RCC). The authors examined the enzymatic